v3.26.1
Stockholders' Equity
 9 Months Ended
Jul. 31, 2026
Equity [Abstract]  
Stockholders’ Equity Stockholders’ Equity
Stock Repurchase Program
From time to time, our Board of Directors authorizes the repurchase of shares of our common stock in open market transactions, privately negotiated transactions (including accelerated share repurchases), issuer tender offers or other financial arrangements or transactions for general corporate purposes, including to obtain shares for the Company’s equity awards and other employee benefit plans. Most recently, on December 13, 2023, our Board of Directors authorized the repurchase of up to 20 million shares of our common stock and canceled all open authorizations effective the same date. The Board of Directors did not fix any expiration date for this repurchase program.
The table below provides, for the periods indicated, information about our share repurchase programs:
Three months ended July 31,Nine months ended July 31,
2026202520262025
Number of shares purchased (in thousands)1,391 1,791 2,955 3,623 
Average price per share (1)
$148.63 $112.40 $146.38 $111.08 
Remaining authorization at July 31 (in thousands)
6,721 11,464 6,721 11,464 
(1)    Average price per share includes costs associated with the repurchases, including accrued excise tax.
Cash Dividends
On March 11, 2026, our Board of Directors approved an increase in our quarterly dividend from $0.25 per share to $0.26 per share. During the three-month periods ended July 31, 2026 and 2025, we declared and paid cash dividends of $0.26 and $0.25 per share, respectively, to our shareholders. During the nine-month periods ended July 31, 2026 and 2025, we declared and paid cash dividends of $0.77 and $0.73 per share, respectively, to our shareholders.
Accumulated Other Comprehensive Income
The changes in each component of accumulated other comprehensive income (“AOCI”), for the periods indicated, were as follows (amounts in thousands):
Three months ended July 31,Nine months ended July 31,
2026202520262025
Employee Retirement Plans
Beginning balance$1,610 $1,325 $1,281 $1,018 
Losses reclassified from AOCI to net income (1)
221 205 662 616 
Less: Tax benefit (2)
(56)(52)(168)(156)
Net losses reclassified from AOCI to net income165 153 494 460 
Other comprehensive income – net of tax165 153 494 460 
Ending balance$1,775 $1,478 $1,775 $1,478 
Derivative Instruments
Beginning balance$17,392 $26,805 $20,991 $30,259 
Gains on derivative instruments— 612 — 1,377 
Less: Tax expense— (157)— (350)
Net gains on derivative instruments— 455 — 1,027 
Gains reclassified from AOCI to net income (3)
(2,902)(3,970)(7,721)(9,358)
Less: Tax expense (2)
734 1,002 1,954 2,364 
Net gains reclassified from AOCI to net income(2,168)(2,968)(5,767)(6,994)
Other comprehensive loss – net of tax(2,168)(2,513)(5,767)(5,967)
Ending balance$15,224 $24,292 $15,224 $24,292 
Total AOCI ending balance$16,999 $25,770 $16,999 $25,770 
(1) Reclassified to “Other income – net”
(2) Reclassified to “Income tax provision”
(3) Reclassified to “Cost of revenues – home sales”